疗效和安全性-话题@MedSci

#疗效和安全性#

431篇内容 | 2636人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1720953, encodeId=14fd1e209530f, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Clin J Am Soc Nephrol：Imarikiren在2型糖尿病和微量白蛋白尿患者中的疗效和安全性, objectType=article, longId=195986, objectId=13e1195986dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13e1195986dc, replyNumber=0, likeNumber=60, createdTime=2021-01-09, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13e1195986dc, moduleTitle=Clin J Am Soc Nephrol：Imarikiren在2型糖尿病和微量白蛋白尿患者中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13e1195986dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720959, encodeId=12991e2095951, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Semin Arthritis Rheu：西罗莫司治疗系统性红斑狼疮的疗效和安全性, objectType=article, longId=198044, objectId=e0ec19804494, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0ec19804494, replyNumber=0, likeNumber=80, createdTime=2021-01-01, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0ec19804494, moduleTitle=Semin Arthritis Rheu：西罗莫司治疗系统性红斑狼疮的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0ec19804494)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720938, encodeId=da5d1e2093885, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Medicine ：针灸治疗慢性萎缩性胃炎的疗效和安全性, objectType=article, longId=189324, objectId=fe59189324f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe59189324f9, replyNumber=0, likeNumber=71, createdTime=2020-10-31, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe59189324f9, moduleTitle=Medicine ：针灸治疗慢性萎缩性胃炎的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe59189324f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720929, encodeId=ccf31e2092998, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Gastroenterology：Vedolizumab皮下注射在溃疡性结肠炎患者中的疗效和安全性, objectType=article, longId=188609, objectId=03481886094b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03481886094b, replyNumber=0, likeNumber=94, createdTime=2020-05-24, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03481886094b, moduleTitle=Gastroenterology：Vedolizumab皮下注射在溃疡性结肠炎患者中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03481886094b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720931, encodeId=b6d21e20931d8, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Thyroid：长期食盐加碘对甲状腺疾病的疗效和安全性分析, objectType=article, longId=188897, objectId=8a5f18889e20, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a5f18889e20, replyNumber=0, likeNumber=58, createdTime=2020-10-01, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a5f18889e20, moduleTitle=Thyroid：长期食盐加碘对甲状腺疾病的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a5f18889e20)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720944, encodeId=14171e2094498, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=J Thromb Haemost：重组人可溶性血栓调节蛋白对脓毒症相关凝血障碍患者中的疗效和安全性 , objectType=article, longId=191574, objectId=045e1915e4d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=045e1915e4d7, replyNumber=0, likeNumber=55, createdTime=2020-04-22, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=045e1915e4d7, moduleTitle=J Thromb Haemost：重组人可溶性血栓调节蛋白对脓毒症相关凝血障碍患者中的疗效和安全性 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=045e1915e4d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720943, encodeId=780f1e2094344, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Clin cancer res：FTD/TPI+伊立替康+贝伐单抗联合治疗晚期消化道肿瘤的疗效和安全性, objectType=article, longId=191573, objectId=25001915e376, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25001915e376, replyNumber=0, likeNumber=92, createdTime=2020-07-30, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25001915e376, moduleTitle=Clin cancer res：FTD/TPI+伊立替康+贝伐单抗联合治疗晚期消化道肿瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25001915e376)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720956, encodeId=38891e2095661, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Ann Rheum Dis：对秋水仙碱耐药的家族性地中海热患者使用卡那单抗的长期疗效和安全性, objectType=article, longId=196491, objectId=400119649139, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=400119649139, replyNumber=0, likeNumber=115, createdTime=2021-04-20, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=400119649139, moduleTitle=Ann Rheum Dis：对秋水仙碱耐药的家族性地中海热患者使用卡那单抗的长期疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=400119649139)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720955, encodeId=58851e20955f9, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Semin Arthritis Rheu：卡那奴单抗治疗Schnitzler综合征的疗效和安全性, objectType=article, longId=196323, objectId=f40c1963232d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f40c1963232d, replyNumber=0, likeNumber=75, createdTime=2021-02-08, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f40c1963232d, moduleTitle=Semin Arthritis Rheu：卡那奴单抗治疗Schnitzler综合征的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f40c1963232d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720954, encodeId=b47a1e2095416, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Metabolism：DPP-4抑制剂在2型糖尿病治疗中的疗效和安全性, objectType=article, longId=196067, objectId=8fa119606e77, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fa119606e77, replyNumber=0, likeNumber=96, createdTime=2021-03-02, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fa119606e77, moduleTitle=Metabolism：DPP-4抑制剂在2型糖尿病治疗中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fa119606e77)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720972, encodeId=22581e20972c6, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Lancet oncol：EZH2抑制剂（EPZ-643）治疗上皮样肉瘤的疗效和安全性, objectType=article, longId=201956, objectId=2c322019565b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c322019565b, replyNumber=0, likeNumber=68, createdTime=2021-08-22, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c322019565b, moduleTitle=Lancet oncol：EZH2抑制剂（EPZ-643）治疗上皮样肉瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c322019565b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720977, encodeId=3eb21e20977be, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Br J Cancer：拓扑替康和贝洛替康在复发性小细胞肺癌单一疗法中的疗效和安全性比较, objectType=article, longId=203653, objectId=a1a820365319, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1a820365319, replyNumber=0, likeNumber=80, createdTime=2021-09-25, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1a820365319, moduleTitle=Br J Cancer：拓扑替康和贝洛替康在复发性小细胞肺癌单一疗法中的疗效和安全性比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1a820365319)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720937, encodeId=5eae1e2093715, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=BMC Infect Dis：基于肾功能的抗结核药物剂量调整对肺结核并发慢性肾脏病的疗效和安全性结果的影响, objectType=article, longId=189215, objectId=e9081892157b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9081892157b, replyNumber=0, likeNumber=104, createdTime=2020-08-12, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9081892157b, moduleTitle=BMC Infect Dis：基于肾功能的抗结核药物剂量调整对肺结核并发慢性肾脏病的疗效和安全性结果的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9081892157b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720975, encodeId=f37c1e20975ed, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=CT-P59治疗轻度COVID-19患者：疗效和安全性得到证实, objectType=article, longId=203135, objectId=8aa72031352f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8aa72031352f, replyNumber=0, likeNumber=56, createdTime=2021-09-26, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8aa72031352f, moduleTitle=CT-P59治疗轻度COVID-19患者：疗效和安全性得到证实, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8aa72031352f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720933, encodeId=aa001e209336e, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=AP&T：钙调神经磷酸酶抑制剂联合维多珠单抗维持治疗对重度类固醇难治性溃疡性结肠炎患者的疗效和安全性, objectType=article, longId=189026, objectId=b88d18902626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b88d18902626, replyNumber=0, likeNumber=53, createdTime=2020-12-26, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b88d18902626, moduleTitle=AP&T：钙调神经磷酸酶抑制剂联合维多珠单抗维持治疗对重度类固醇难治性溃疡性结肠炎患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b88d18902626)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720928, encodeId=01351e20928d6, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Gastroenterology：依他西莫在溃疡性结肠炎患者的疗效和安全性分析, objectType=article, longId=188608, objectId=9bf0188608bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bf0188608bf, replyNumber=0, likeNumber=54, createdTime=2020-12-22, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bf0188608bf, moduleTitle=Gastroenterology：依他西莫在溃疡性结肠炎患者的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bf0188608bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720971, encodeId=9bf41e2097102, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Lancet Infect Dis：头孢唑烷-他唑巴坦VS美罗培南治疗院内肺炎的疗效和安全性, objectType=article, longId=201783, objectId=ce17201e8378, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce17201e8378, replyNumber=0, likeNumber=66, createdTime=2021-07-31, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce17201e8378, moduleTitle=Lancet Infect Dis：头孢唑烷-他唑巴坦VS美罗培南治疗院内肺炎的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce17201e8378)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720942, encodeId=d1231e20942f1, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Ann Rheum Dis：他尼珠单抗皮下给药治疗髋部或膝部骨关节炎的疗效和安全性, objectType=article, longId=191514, objectId=a62b191514ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a62b191514ea, replyNumber=0, likeNumber=62, createdTime=2021-02-19, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a62b191514ea, moduleTitle=Ann Rheum Dis：他尼珠单抗皮下给药治疗髋部或膝部骨关节炎的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a62b191514ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720926, encodeId=b0531e2092678, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=J Clin Oncol：曲妥珠单抗治疗HER2低表达乳腺癌的疗效和安全性, objectType=article, longId=188283, objectId=be8d18828340, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be8d18828340, replyNumber=0, likeNumber=59, createdTime=2020-02-22, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be8d18828340, moduleTitle=J Clin Oncol：曲妥珠单抗治疗HER2低表达乳腺癌的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be8d18828340)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720952, encodeId=f2c71e20952c6, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Blood：纳武单抗用于alloHCT后复发的血液恶性肿瘤的疗效和安全性, objectType=article, longId=195515, objectId=098c1955156f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=098c1955156f, replyNumber=0, likeNumber=90, createdTime=2021-03-26, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=098c1955156f, moduleTitle=Blood：纳武单抗用于alloHCT后复发的血液恶性肿瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=098c1955156f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

疗效和安全性

2020-05-29

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Clin J Am Soc Nephrol：Imarikiren在2型糖尿病和微量白蛋白尿患者中的疗效和安全性

2021-01-09

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Semin Arthritis Rheu：西罗莫司治疗系统性红斑狼疮的疗效和安全性

2021-01-01

hb2008ye (审核中...)

前往app查看评论内容

#疗效和安全性#

Medicine ：针灸治疗慢性萎缩性胃炎的疗效和安全性

2020-10-31

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Gastroenterology：Vedolizumab皮下注射在溃疡性结肠炎患者中的疗效和安全性

2020-05-24

hb2008ye (审核中...)

前往app查看评论内容

#疗效和安全性#

Thyroid：长期食盐加碘对甲状腺疾病的疗效和安全性分析

2020-10-01

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

J Thromb Haemost：重组人可溶性血栓调节蛋白对脓毒症相关凝血障碍患者中的疗效和安全性

2020-04-22

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Clin cancer res：FTD/TPI+伊立替康+贝伐单抗联合治疗晚期消化道肿瘤的疗效和安全性

2020-07-30

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Ann Rheum Dis：对秋水仙碱耐药的家族性地中海热患者使用卡那单抗的长期疗效和安全性

2021-04-20

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Semin Arthritis Rheu：卡那奴单抗治疗Schnitzler综合征的疗效和安全性

2021-02-08

仁医06 (审核中...)

前往app查看评论内容

#疗效和安全性#

Metabolism：DPP-4抑制剂在2型糖尿病治疗中的疗效和安全性

2021-03-02

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Lancet oncol：EZH2抑制剂（EPZ-643）治疗上皮样肉瘤的疗效和安全性

2021-08-22

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Br J Cancer：拓扑替康和贝洛替康在复发性小细胞肺癌单一疗法中的疗效和安全性比较

2021-09-25

hb2008ye (审核中...)

前往app查看评论内容

#疗效和安全性#

BMC Infect Dis：基于肾功能的抗结核药物剂量调整对肺结核并发慢性肾脏病的疗效和安全性结果的影响

2020-08-12

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

CT-P59治疗轻度COVID-19患者：疗效和安全性得到证实

2021-09-26

hb2008ye (审核中...)

前往app查看评论内容

#疗效和安全性#

AP&T：钙调神经磷酸酶抑制剂联合维多珠单抗维持治疗对重度类固醇难治性溃疡性结肠炎患者的疗效和安全性

2020-12-26

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Gastroenterology：依他西莫在溃疡性结肠炎患者的疗效和安全性分析

2020-12-22

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Lancet Infect Dis：头孢唑烷-他唑巴坦VS美罗培南治疗院内肺炎的疗效和安全性

2021-07-31

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Ann Rheum Dis：他尼珠单抗皮下给药治疗髋部或膝部骨关节炎的疗效和安全性

2021-02-19

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

J Clin Oncol：曲妥珠单抗治疗HER2低表达乳腺癌的疗效和安全性

2020-02-22

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Blood：纳武单抗用于alloHCT后复发的血液恶性肿瘤的疗效和安全性

2021-03-26

科室
- - 订阅+
  - 更多科室
工具
服务